advances-and-challenges-in-the-dosage-form-design-for-the-treatment-of-parkinson
 

http://www.discoverymedicine.com/Min...nsons-disease/

very interesting, seems except for a few small companies like impax labs - their rytary carbidopa/l-dopa capsule waiting for final FDA approval - big pharma not interested in developing better extended release pill even though the technology seems available.